Status:
COMPLETED
Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes
Lead Sponsor:
Providence VA Medical Center
Collaborating Sponsors:
Sandra A. Daugherty Foundation
Conditions:
Diabetes
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglo...
Detailed Description
Our project intends to study the 6-month efficacy of a pharmacist-led group intervention program that simultaneously target diabetes, hypertension and dyslipidemia. We hypothesize that pharmacist-led ...
Eligibility Criteria
Inclusion
- type 2 diabetes mellitus,
- \>18 years old,
- with a documented HbA1c more than 7.0%,
- an LDL cholesterol \>100 mg/dl AND a blood pressure \>130/80 mm Hg documented at least once in the medical records within the last 6 months, and
- willing to comply with the study interventions will be eligible for the study.
Exclusion
- pregnancy,
- unable to attend the group sessions,
- disease conditions such as psychiatric instability (acutely suicidal, psychotic) or organic brain injury that preclude them from performing diabetes self-care,
- enrolled in the Providence VAMC's Telehealth program
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00409240
Start Date
October 1 2006
End Date
June 1 2008
Last Update
April 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Providence VAMC
Providence, Rhode Island, United States, 02908